COVID-19: Protection of IP for AI tools

Nine days before the World Health Organization officially notified the public of a flu-like outbreak in China, BlueDot, a Canadian artificial intelligence (AI) startup, warned its clients of a potential outbreak near a market in Wuhan, China.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

What 2020 means for the life sciences

15 December 2020 Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.

Biotechnology

Bioinformatics: a guide to IP protection

12 June 2023 AI and computer-related inventions that use biological data are hot property, but what IP is best to protect them? Lauris Kemp, Claire Irvine, and Susan Keston of HGF explain.

Europe

UK implored to back COVID-19 IP waiver at WTO

11 March 2021 The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions.

More on this story

Big Pharma

What 2020 means for the life sciences

15 December 2020 Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.

Biotechnology

Bioinformatics: a guide to IP protection

12 June 2023 AI and computer-related inventions that use biological data are hot property, but what IP is best to protect them? Lauris Kemp, Claire Irvine, and Susan Keston of HGF explain.

Europe

UK implored to back COVID-19 IP waiver at WTO

11 March 2021 The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions.

More on this story

Big Pharma

What 2020 means for the life sciences

15 December 2020 Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.

Biotechnology

Bioinformatics: a guide to IP protection

12 June 2023 AI and computer-related inventions that use biological data are hot property, but what IP is best to protect them? Lauris Kemp, Claire Irvine, and Susan Keston of HGF explain.

Europe

UK implored to back COVID-19 IP waiver at WTO

11 March 2021 The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions.

More features

Sarepta wins $115M in patent dispute over muscular dystrophy drug

CREATES Act unfairly tips the scales to generics

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York

‘A marathon and a sprint at the same time’: How we won $452m damages

Judge denies Intellia bid to throw out suit over $100m Regeneron pact

Trump’s return sparks calls for pro-patent agenda

COVID-19: Protection of IP for AI tools

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features